Shader, Richard I.

Use of benzodiazepines in anxiety disorders

Wood, A. J. J., Shader, R. I., & Greenblatt, D. J. (1993) · New England Journal of Medicine

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesSynthesis and pharmacology of benzodiazepine derivatives

Cited by 341

Sensitivity to triazolam in the elderly

Greenblatt, D. J., Harmatz, J. S., Shapiro, L., Engelhardt, N., Gouthro, T. A., & Shader, R. I. (1991) · New England Journal of Medicine

Pharmaceutical Practices and Patient OutcomesAnesthesia and Sedative Agents

Cited by 258

Pharmacokinetics and bioavailability of intravenous, intramuscular, and oral lorazepam in humans

Greenblatt, D. J., Shader, R. I., Franke, K., MacLaughlin, D. S., Harmatz, J. S., Allen, M. D., Werner, A., & Woo, E. (1979) · Journal of Pharmaceutical Sciences

Pharmacogenetics and Drug MetabolismAnesthesia and Sedative Agents

Cited by 197

Pharmacokinetic comparison of sublingual lorazepam with intravenous, intramuscular, and oral lorazepam

Greenblatt, D. J., Divoll, M., Harmatz, J. S., & Shader, R. I. (1982) · Journal of Pharmaceutical Sciences

Pharmacogenetics and Drug MetabolismAnesthesia and Sedative Agents

Cited by 134

Pharmacokinetic properties of zolpidem in elderly and young adults: possible modulation by testosterone in men

Olubodun, J. O., Ochs, H. R., Von Moltke, L. L., Roubenoff, R., Hesse, L. M., Harmatz, J. S., Shader, R. I., & Greenblatt, D. J. (2003) · British Journal of Clinical Pharmacology

Pharmacogenetics and Drug MetabolismPharmaceutical studies and practices

Cited by 104

Implications of Altered Drug Disposition in the Elderly: Studies of Benzodiazepines

Greenblatt, D. J., Shader, R. I., & Harmatz, J. S. (1989) · The Journal of Clinical Pharmacology

Pharmaceutical Practices and Patient OutcomesPharmacogenetics and Drug Metabolism

Cited by 102

The Influence of Obesity on the Pharmacokinetics of Oral Alprazolam and Triazolam

Abernethy, D. R., Greenblatt, D. J., Divoll, M., Smith, R. B., & Shader, R. I. (1984) · Clinical Pharmacokinetics

Pharmacogenetics and Drug MetabolismAnesthesia and Sedative Agents

Cited by 99

Effect of Gradual Withdrawal on the Rebound Sleep Disorder after Discontinuation of Triazolam

Greenblatt, D. J., Harmatz, J. S., Zinny, M. A., & Shader, R. I. (1987) · New England Journal of Medicine

Sleep and related disordersSubstance Abuse Treatment and Outcomes

Cited by 96

Age and gender effects on the pharmacokinetics and pharmacodynamics of triazolam, a cytochrome P450 3A substrate

GREENBLATT, D., HARMATZ, J., VONMOLTKE, L., WRIGHT, C., & SHADER, R. (2004) · Clinical Pharmacology & Therapeutics

Pharmacogenetics and Drug MetabolismPharmaceutical studies and practices

Cited by 93

Benzodiazepines: it's time to return to the evidence

Silberman, E., Balon, R., Starcevic, V., Shader, R., Cosci, F., Fava, G. A., Nardi, A. E., Salzman, C., & Sonino, N. (2021) · The British Journal of Psychiatry

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesSynthesis and pharmacology of benzodiazepine derivatives

Cited by 54

From Disordered Eating to Addiction: The “Food Drug” in Bulimia Nervosa

Umberg, E. N., Shader, R. I., Hsu, L. K. G., & Greenblatt, D. J. (2012) · Journal of Clinical Psychopharmacology

Eating Disorders and BehaviorsNutrition, Health and Food Behavior

Cited by 52

Marijuana and hostility in a small-group setting

Salzman, C., van der Kolk, B. A., & Shader, R. I. (1976) · American Journal of Psychiatry

Cannabis and Cannabinoid ResearchNeurotransmitter Receptor Influence on Behavior

Cited by 48

Desmethyldiazepam pharmacokinetics: studies following intravenous and oral desmethyldiazepam, oral clorazepate, and intravenous diazepam

Greenblatt, D. J., Divoll, M. K., Soong, M. H., Boxenbaum, H. G., Harmatz, J. S., & Shader, R. I. (1988) · The Journal of Clinical Pharmacology

Pharmacogenetics and Drug MetabolismAnesthesia and Sedative Agents

Cited by 42

International Task Force on Benzodiazepines

Balon, R., Chouinard, G., Cosci, F., Dubovsky, S. L., Fava, G. A., Freire, R. C., Greenblatt, D. J., Krystal, J. H., Nardi, A. E., Rickels, K., et al. (2018) · Psychotherapy and Psychosomatics

Pharmaceutical Practices and Patient OutcomesAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 35

Pharmocokinetics and pharmacodynamics of single-dose triazolam: electroencephalography compared with the Digit-Symbol Substitution Test

Greenblatt, D. J., Gan, L., Harmatz, J. S., & Shader, R. I. (2005) · British Journal of Clinical Pharmacology

Anesthesia and Sedative AgentsPharmacogenetics and Drug Metabolism

Cited by 33

Alterations in pharmacodynamics of anxiolytics in abstinent alcoholic men: subjective responses, abuse liability, and electroencephalographic effects of alprazolam, diazepam, and buspirone

Ciraulo, D. A., Barnhill, J. G., Ciraulo, A. M., Sarid‐Segal, O., Knapp, C., Greenblatt, D. J., & Shader, R. I. (1997) · The Journal of Clinical Pharmacology

Substance Abuse Treatment and OutcomesNeurotransmitter Receptor Influence on Behavior

Cited by 28

Chronic benzodiazepine administration

Galpern, W. R., Miller, L. G., greenblatt, D. J., Szabo, G. K., Browne, T. R., & Shader, R. I. (1991) · Biochemical Pharmacology

Neuroscience and Neuropharmacology ResearchEpilepsy research and treatment

Cited by 17

Benzodiazepines, antidepressants and addiction: A plea for conceptual rigor and consistency

Balon, R., Silberman, E. K., Starcevic, V., Cosci, F., Freire, R. C., Nardi, A. E., Rickels, K., & Shader, R. (2019) · Journal of Psychopharmacology

Substance Abuse Treatment and OutcomesTreatment of Major Depression

Cited by 7